Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Hepatocyte Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Hepatocyte Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Pharma & Healthcare
Published Date: 2026-01-04
Pages: 77 Pages
Report ld: 5554824
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hepatocyte Growth Factor Market Size(US$)
CAGR 2026-2032
28.0%
Market Size,2032
USD 534
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 121 million
Market Forecast in 2032(Value)
US$ 534 million
CAGR
28.0%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hepatocyte Growth Factor market size was US$ 97 million in 2025 and is forecast to reach a readjusted size of US$ 534 million by 2032 with a CAGR of 28.0% during the forecast period 2026-2032.
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Current drug development targeting the HGF pathway is bifurcated into neuroregeneration and oncology tracks, with clinical pipelines focused on indications such as diabetic neuropathy, ALS, spinal cord injury, stroke, and various solid tumors including NSCLC and gastric cancer. Globally, companies like Helixmith, AnGes MG, and Kringle Pharma are advancing gene therapies and recombinant proteins for neurological indications. Athira Pharma and AVEO are developing small molecules and antibodies targeting the HGF/c-Met axis, while Exelixis and Molecular Partners pursue broader oncology strategies via multi-target approaches. Beijing Northland represents China’s early-stage involvement in this area. The landscape is marked by diversified modalities and parallel development paths, with several assets reaching late-stage trials or conditional approvals, indicating strong commercialization potential in regenerative medicine and rare diseases.
The global Hepatocyte Growth Factor market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
By Company
- Helixsmith
- Exelixis
- AnGes MG
- Athira Pharma
- AVEO Pharmaceuticals
- Molecular Partners
- Kringle Pharma
- Beijing Northland
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Phase III (Ongoing)
- Phase II (Approved)
- Phase II (Ongoing)
- Phase 1
- Preclinical
- Approved / Marketed
Segment by Application
- Oncology
- Cardiovascular
- Central Nervous System
- Hematological Disorders
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Hepatocyte Growth Factor sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Hepatocyte Growth Factor manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Hepatocyte Growth Factor product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Hepatocyte Growth Factor value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hepatocyte Growth Factor Product Scope
1.2 Hepatocyte Growth Factor by Type
1.2.1 Global Hepatocyte Growth Factor Sales by Type (2021, 2025 & 2032)
1.2.2 Phase III (Ongoing)
1.2.3 Phase II (Approved)
1.2.4 Phase II (Ongoing)
1.2.5 Phase 1
1.2.6 Preclinical
1.2.7 Approved / Marketed
1.3 Hepatocyte Growth Factor by Application
1.3.1 Global Hepatocyte Growth Factor Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Hematological Disorders
1.3.6 Others
1.4 Global Hepatocyte Growth Factor Market Estimates and Forecasts (2021-2032)
1.4.1 Global Hepatocyte Growth Factor Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Hepatocyte Growth Factor Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Hepatocyte Growth Factor Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Hepatocyte Growth Factor Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Hepatocyte Growth Factor Historical Market Scenario by Region (2021-2026)
2.2.1 Global Hepatocyte Growth Factor Sales Market Share by Region (2021-2026)
2.2.2 Global Hepatocyte Growth Factor Revenue Market Share by Region (2021-2026)
2.3 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Hepatocyte Growth Factor Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Hepatocyte Growth Factor Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Hepatocyte Growth Factor Market Size and Prospects (2021-2032)
2.4.2 Europe Hepatocyte Growth Factor Market Size and Prospects (2021-2032)
2.4.3 China Hepatocyte Growth Factor Market Size and Prospects (2021-2032)
2.4.4 Japan Hepatocyte Growth Factor Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Hepatocyte Growth Factor Historical Market Review by Type (2021-2026)
3.1.1 Global Hepatocyte Growth Factor Sales by Type (2021-2026)
3.1.2 Global Hepatocyte Growth Factor Revenue by Type (2021-2026)
3.1.3 Global Hepatocyte Growth Factor Average Price by Type (2021-2026)
3.2 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Hepatocyte Growth Factor Sales Forecast by Type (2027-2032)
3.2.2 Global Hepatocyte Growth Factor Revenue Forecast by Type (2027-2032)
3.2.3 Global Hepatocyte Growth Factor Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Hepatocyte Growth Factor
4 Global Market Size by Application
4.1 Global Hepatocyte Growth Factor Historical Market Review by Application (2021-2026)
4.1.1 Global Hepatocyte Growth Factor Sales by Application (2021-2026)
4.1.2 Global Hepatocyte Growth Factor Revenue by Application (2021-2026)
4.1.3 Global Hepatocyte Growth Factor Average Price by Application (2021-2026)
4.2 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Hepatocyte Growth Factor Sales Forecast by Application (2027-2032)
4.2.2 Global Hepatocyte Growth Factor Revenue Forecast by Application (2027-2032)
4.2.3 Global Hepatocyte Growth Factor Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Hepatocyte Growth Factor Applications
5 Competition Landscape by Players
5.1 Global Hepatocyte Growth Factor Sales by Player (2021-2026)
5.2 Global Top Hepatocyte Growth Factor Players by Revenue (2021-2026)
5.3 Global Hepatocyte Growth Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Hepatocyte Growth Factor revenue as of 2025
5.4 Global Hepatocyte Growth Factor Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Hepatocyte Growth Factor, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Hepatocyte Growth Factor, Product Type & Application
5.7 Global Key Manufacturers of Hepatocyte Growth Factor, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Hepatocyte Growth Factor Sales by Company
6.1.1.1 North America Hepatocyte Growth Factor Sales by Company (2021-2026)
6.1.1.2 North America Hepatocyte Growth Factor Revenue by Company (2021-2026)
6.1.2 North America Hepatocyte Growth Factor Sales Breakdown by Type (2021-2026)
6.1.3 North America Hepatocyte Growth Factor Sales Breakdown by Application (2021-2026)
6.1.4 North America Hepatocyte Growth Factor Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Hepatocyte Growth Factor Sales by Company
6.2.1.1 Europe Hepatocyte Growth Factor Sales by Company (2021-2026)
6.2.1.2 Europe Hepatocyte Growth Factor Revenue by Company (2021-2026)
6.2.2 Europe Hepatocyte Growth Factor Sales Breakdown by Type (2021-2026)
6.2.3 Europe Hepatocyte Growth Factor Sales Breakdown by Application (2021-2026)
6.2.4 Europe Hepatocyte Growth Factor Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Hepatocyte Growth Factor Sales by Company
6.3.1.1 China Hepatocyte Growth Factor Sales by Company (2021-2026)
6.3.1.2 China Hepatocyte Growth Factor Revenue by Company (2021-2026)
6.3.2 China Hepatocyte Growth Factor Sales Breakdown by Type (2021-2026)
6.3.3 China Hepatocyte Growth Factor Sales Breakdown by Application (2021-2026)
6.3.4 China Hepatocyte Growth Factor Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Hepatocyte Growth Factor Sales by Company
6.4.1.1 Japan Hepatocyte Growth Factor Sales by Company (2021-2026)
6.4.1.2 Japan Hepatocyte Growth Factor Revenue by Company (2021-2026)
6.4.2 Japan Hepatocyte Growth Factor Sales Breakdown by Type (2021-2026)
6.4.3 Japan Hepatocyte Growth Factor Sales Breakdown by Application (2021-2026)
6.4.4 Japan Hepatocyte Growth Factor Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Helixsmith
7.1.1 Helixsmith Company Information
7.1.2 Helixsmith Business Overview
7.1.3 Helixsmith Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Helixsmith Hepatocyte Growth Factor Products Offered
7.1.5 Helixsmith Recent Development
7.2 Exelixis
7.2.1 Exelixis Company Information
7.2.2 Exelixis Business Overview
7.2.3 Exelixis Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Exelixis Hepatocyte Growth Factor Products Offered
7.2.5 Exelixis Recent Development
7.3 AnGes MG
7.3.1 AnGes MG Company Information
7.3.2 AnGes MG Business Overview
7.3.3 AnGes MG Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
7.3.4 AnGes MG Hepatocyte Growth Factor Products Offered
7.3.5 AnGes MG Recent Development
7.4 Athira Pharma
7.4.1 Athira Pharma Company Information
7.4.2 Athira Pharma Business Overview
7.4.3 Athira Pharma Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Athira Pharma Hepatocyte Growth Factor Products Offered
7.4.5 Athira Pharma Recent Development
7.5 AVEO Pharmaceuticals
7.5.1 AVEO Pharmaceuticals Company Information
7.5.2 AVEO Pharmaceuticals Business Overview
7.5.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
7.5.4 AVEO Pharmaceuticals Hepatocyte Growth Factor Products Offered
7.5.5 AVEO Pharmaceuticals Recent Development
7.6 Molecular Partners
7.6.1 Molecular Partners Company Information
7.6.2 Molecular Partners Business Overview
7.6.3 Molecular Partners Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Molecular Partners Hepatocyte Growth Factor Products Offered
7.6.5 Molecular Partners Recent Development
7.7 Kringle Pharma
7.7.1 Kringle Pharma Company Information
7.7.2 Kringle Pharma Business Overview
7.7.3 Kringle Pharma Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Kringle Pharma Hepatocyte Growth Factor Products Offered
7.7.5 Kringle Pharma Recent Development
7.8 Beijing Northland
7.8.1 Beijing Northland Company Information
7.8.2 Beijing Northland Business Overview
7.8.3 Beijing Northland Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Beijing Northland Hepatocyte Growth Factor Products Offered
7.8.5 Beijing Northland Recent Development
8 Hepatocyte Growth Factor Manufacturing Cost Analysis
8.1 Hepatocyte Growth Factor Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Hepatocyte Growth Factor
8.4 Hepatocyte Growth Factor Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Hepatocyte Growth Factor Distributors List
9.3 Hepatocyte Growth Factor Customers
10 Hepatocyte Growth Factor Market Dynamics
10.1 Hepatocyte Growth Factor Industry Trends
10.2 Hepatocyte Growth Factor Market Drivers
10.3 Hepatocyte Growth Factor Market Challenges
10.4 Hepatocyte Growth Factor Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hepatocyte Growth Factor Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Hepatocyte Growth Factor Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Hepatocyte Growth Factor Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Hepatocyte Growth Factor Sales (K Units) by Region (2021-2026)
Table 5. Global Hepatocyte Growth Factor Sales Market Share by Region (2021-2026)
Table 6. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Hepatocyte Growth Factor Revenue Share by Region (2021-2026)
Table 8. Global Hepatocyte Growth Factor Sales (K Units) Forecast by Region (2027-2032)
Table 9. Global Hepatocyte Growth Factor Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Hepatocyte Growth Factor Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Hepatocyte Growth Factor Revenue Share Forecast by Region (2027-2032)
Table 12. Global Hepatocyte Growth Factor Sales by Type (K Units) & (2021-2026)
Table 13. Global Hepatocyte Growth Factor Sales Share by Type (2021-2026)
Table 14. Global Hepatocyte Growth Factor Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Hepatocyte Growth Factor Average Price by Type (USD/Unit) & (2021-2026)
Table 16. Global Hepatocyte Growth Factor Sales by Type (K Units) & (2027-2032)
Table 17. Global Hepatocyte Growth Factor Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Hepatocyte Growth Factor Average Price by Type (USD/Unit) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Hepatocyte Growth Factor Sales by Application (K Units) & (2021-2026)
Table 21. Global Hepatocyte Growth Factor Sales Share by Application (2021-2026)
Table 22. Global Hepatocyte Growth Factor Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Hepatocyte Growth Factor Average Price by Application (USD/Unit) & (2021-2026)
Table 24. Global Hepatocyte Growth Factor Sales by Application (K Units) & (2027-2032)
Table 25. Global Hepatocyte Growth Factor Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Hepatocyte Growth Factor Average Price by Application (USD/Unit) & (2027-2032)
Table 27. New Sources of Growth in Hepatocyte Growth Factor Applications
Table 28. Global Hepatocyte Growth Factor Sales by Company (K Units) & (2021-2026)
Table 29. Global Hepatocyte Growth Factor Sales Share by Company (2021-2026)
Table 30. Global Hepatocyte Growth Factor Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Hepatocyte Growth Factor Revenue Share by Company (2021-2026)
Table 32. Global Hepatocyte Growth Factor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatocyte Growth Factor as of 2025)
Table 33. Global Market Hepatocyte Growth Factor Average Price by Company (USD/Unit) & (2021-2026)
Table 34. Global Key Manufacturers of Hepatocyte Growth Factor, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Hepatocyte Growth Factor, Product Type & Application
Table 36. Global Key Manufacturers of Hepatocyte Growth Factor, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Hepatocyte Growth Factor Sales by Company (2021-2026) & (K Units)
Table 39. North America Hepatocyte Growth Factor Sales Market Share by Company (2021-2026)
Table 40. North America Hepatocyte Growth Factor Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Hepatocyte Growth Factor Revenue Market Share by Company (2021-2026)
Table 42. North America Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units)
Table 43. North America Hepatocyte Growth Factor Sales Market Share by Type (2021-2026)
Table 44. North America Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units)
Table 45. North America Hepatocyte Growth Factor Sales Market Share by Application (2021-2026)
Table 46. Europe Hepatocyte Growth Factor Sales by Company (2021-2026) & (K Units)
Table 47. Europe Hepatocyte Growth Factor Sales Market Share by Company (2021-2026)
Table 48. Europe Hepatocyte Growth Factor Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Hepatocyte Growth Factor Revenue Market Share by Company (2021-2026)
Table 50. Europe Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units)
Table 51. Europe Hepatocyte Growth Factor Sales Market Share by Type (2021-2026)
Table 52. Europe Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units)
Table 53. Europe Hepatocyte Growth Factor Sales Market Share by Application (2021-2026)
Table 54. China Hepatocyte Growth Factor Sales by Company (2021-2026) & (K Units)
Table 55. China Hepatocyte Growth Factor Sales Market Share by Company (2021-2026)
Table 56. China Hepatocyte Growth Factor Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Hepatocyte Growth Factor Revenue Market Share by Company (2021-2026)
Table 58. China Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units)
Table 59. China Hepatocyte Growth Factor Sales Market Share by Type (2021-2026)
Table 60. China Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units)
Table 61. China Hepatocyte Growth Factor Sales Market Share by Application (2021-2026)
Table 62. Japan Hepatocyte Growth Factor Sales by Company (2021-2026) & (K Units)
Table 63. Japan Hepatocyte Growth Factor Sales Market Share by Company (2021-2026)
Table 64. Japan Hepatocyte Growth Factor Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Hepatocyte Growth Factor Revenue Market Share by Company (2021-2026)
Table 66. Japan Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units)
Table 67. Japan Hepatocyte Growth Factor Sales Market Share by Type (2021-2026)
Table 68. Japan Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units)
Table 69. Japan Hepatocyte Growth Factor Sales Market Share by Application (2021-2026)
Table 70. Helixsmith Company Information
Table 71. Helixsmith Description and Business Overview
Table 72. Helixsmith Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 73. Helixsmith Hepatocyte Growth Factor Product
Table 74. Helixsmith Recent Development
Table 75. Exelixis Company Information
Table 76. Exelixis Description and Business Overview
Table 77. Exelixis Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 78. Exelixis Hepatocyte Growth Factor Product
Table 79. Exelixis Recent Development
Table 80. AnGes MG Company Information
Table 81. AnGes MG Description and Business Overview
Table 82. AnGes MG Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 83. AnGes MG Hepatocyte Growth Factor Product
Table 84. AnGes MG Recent Development
Table 85. Athira Pharma Company Information
Table 86. Athira Pharma Description and Business Overview
Table 87. Athira Pharma Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 88. Athira Pharma Hepatocyte Growth Factor Product
Table 89. Athira Pharma Recent Development
Table 90. AVEO Pharmaceuticals Company Information
Table 91. AVEO Pharmaceuticals Description and Business Overview
Table 92. AVEO Pharmaceuticals Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 93. AVEO Pharmaceuticals Hepatocyte Growth Factor Product
Table 94. AVEO Pharmaceuticals Recent Development
Table 95. Molecular Partners Company Information
Table 96. Molecular Partners Description and Business Overview
Table 97. Molecular Partners Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 98. Molecular Partners Hepatocyte Growth Factor Product
Table 99. Molecular Partners Recent Development
Table 100. Kringle Pharma Company Information
Table 101. Kringle Pharma Description and Business Overview
Table 102. Kringle Pharma Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 103. Kringle Pharma Hepatocyte Growth Factor Product
Table 104. Kringle Pharma Recent Development
Table 105. Beijing Northland Company Information
Table 106. Beijing Northland Description and Business Overview
Table 107. Beijing Northland Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 108. Beijing Northland Hepatocyte Growth Factor Product
Table 109. Beijing Northland Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Hepatocyte Growth Factor Distributors List
Table 113. Hepatocyte Growth Factor Customers List
Table 114. Hepatocyte Growth Factor Market Trends
Table 115. Hepatocyte Growth Factor Market Drivers
Table 116. Hepatocyte Growth Factor Market Challenges
Table 117. Hepatocyte Growth Factor Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatocyte Growth Factor Product Picture
Figure 2. Global Hepatocyte Growth Factor Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Hepatocyte Growth Factor Sales Market Share by Type in 2025 & 2032
Figure 4. Phase III (Ongoing) Product Picture
Figure 5. Phase II (Approved) Product Picture
Figure 6. Phase II (Ongoing) Product Picture
Figure 7. Phase 1 Product Picture
Figure 8. Preclinical Product Picture
Figure 9. Approved / Marketed Product Picture
Figure 10. Global Hepatocyte Growth Factor Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 11. Global Hepatocyte Growth Factor Sales Market Share by Application in 2025 & 2032
Figure 12. Oncology Examples
Figure 13. Cardiovascular Examples
Figure 14. Central Nervous System Examples
Figure 15. Hematological Disorders Examples
Figure 16. Others Examples
Figure 17. Global Hepatocyte Growth Factor Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global Hepatocyte Growth Factor Sales Growth Rate (2021-2032) & (US$ Million)
Figure 19. Global Hepatocyte Growth Factor Sales (K Units) Growth Rate (2021-2032)
Figure 20. Global Hepatocyte Growth Factor Price Trends Growth Rate (2021-2032) & (USD/Unit)
Figure 21. Hepatocyte Growth Factor Report Years Considered
Figure 22. Global Market Hepatocyte Growth Factor Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 23. Global Hepatocyte Growth Factor Revenue Market Share by Region: 2021 VS 2025
Figure 24. North America Hepatocyte Growth Factor Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. North America Hepatocyte Growth Factor Sales (K Units) Growth Rate (2021-2032)
Figure 26. Europe Hepatocyte Growth Factor Revenue (US$ Million) Growth Rate (2021-2032)
Figure 27. Europe Hepatocyte Growth Factor Sales (K Units) Growth Rate (2021-2032)
Figure 28. China Hepatocyte Growth Factor Revenue (US$ Million) Growth Rate (2021-2032)
Figure 29. China Hepatocyte Growth Factor Sales (K Units) Growth Rate (2021-2032)
Figure 30. Japan Hepatocyte Growth Factor Revenue (US$ Million) Growth Rate (2021-2032)
Figure 31. Japan Hepatocyte Growth Factor Sales (K Units) Growth Rate (2021-2032)
Figure 32. Global Hepatocyte Growth Factor Revenue Share by Type (2021-2026)
Figure 33. Global Hepatocyte Growth Factor Sales Share by Type (2027-2032)
Figure 34. Global Hepatocyte Growth Factor Revenue Share by Type (2027-2032)
Figure 35. Global Hepatocyte Growth Factor Revenue Share by Application (2021-2026)
Figure 36. Global Hepatocyte Growth Factor Revenue Growth Rate by Application in 2021 & 2025
Figure 37. Global Hepatocyte Growth Factor Sales Share by Application (2027-2032)
Figure 38. Global Hepatocyte Growth Factor Revenue Share by Application (2027-2032)
Figure 39. Global Hepatocyte Growth Factor Sales Share by Company (2025)
Figure 40. Global Hepatocyte Growth Factor Revenue Share by Company (2025)
Figure 41. Global 5 Largest Hepatocyte Growth Factor Players Market Share by Revenue in Hepatocyte Growth Factor: 2021 & 2025
Figure 42. Hepatocyte Growth Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 43. Manufacturing Cost Structure of Hepatocyte Growth Factor
Figure 44. Manufacturing Process Analysis of Hepatocyte Growth Factor
Figure 45. Hepatocyte Growth Factor Industrial Chain
Figure 46. Channels of Distribution (Direct Vs Distribution)
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Hepatocyte Growth Factor in 2026?
The global market size of Hepatocyte Growth Factor in 2026 was 121 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Hepatocyte Growth Factor in 2032?
Which companies rank high in the global Hepatocyte Growth Factor market?
What is the annual compound growth rate of the global Hepatocyte Growth Factor market size from 2026 to 2032?
Related Reports
Global Hepatocyte Growth Factor Market Research Report 2026
The global Hepatocyte Growth Factor market was valued at US$ 97 million in 2025 and is anticipated to reach US$ 534 million by 2032, at a CAGR of 28.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Hepatocyte Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 97 million in 2025 and is projected to reach US$ 534 million, growing at a CAGR of 28.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 93
USD 3950.00
(Single User License)
Hepatocyte Growth Factor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 426 million by 2031 with a CAGR of 28.0% during the forecast period 2025-2031.
Published Date: 2025-10-21
Pages: 105
USD 3950.00
(Single User License)
Global Hepatocyte Growth Factor Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hepatocyte Growth Factor market is projected to grow from US$ 75.8 million in 2024 to US$ 426 million by 2031, at a CAGR of 28.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 143
USD 4900.00
(Single User License)
Global Hepatocyte Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hepatocyte Growth Factor market size was US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 426 million by 2031 with a CAGR of 28.0% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 80
USD 4250.00
(Single User License)
Global Hepatocyte Growth Factor Market Research Report 2025
The global market for Hepatocyte Growth Factor was valued at US$ 75.8 million in the year 2024 and is projected to reach a revised size of US$ 426 million by 2031, growing at a CAGR of 28.0% during the forecast period.
Published Date: 2025-08-13
Pages: 82
USD 2900.00
(Single User License)
Global Hepatocyte Growth Factor Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million and is forecast to reach approximately US$ 464 million by 2031 with a CAGR of 30.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 140
USD 5900.00
(Single User License)
Hepatocyte Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 464 million by 2031 with a CAGR of 30.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 98
USD 3950.00
(Single User License)
Global Hepatocyte Growth Factor Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Published Date: 2024-04-17
Pages: 138
USD 5600.00
(Single User License)
Global Hepatocyte Growth Factor Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Published Date: 2024-04-16
Pages: 128
USD 5900.00
(Single User License)
Global Hepatocyte Growth Factor Market Research Report 2026
The global Hepatocyte Growth Factor market was valued at US$ 97 million in 2025 and is anticipated to reach US$ 534 million by 2032, at a CAGR of 28.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)Hepatocyte Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 97 million in 2025 and is projected to reach US$ 534 million, growing at a CAGR of 28.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 93
USD 3950.00 (Single User License)Hepatocyte Growth Factor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 426 million by 2031 with a CAGR of 28.0% during the forecast period 2025-2031.
Published: 2025-10-21
Pages: 105
USD 3950.00 (Single User License)Global Hepatocyte Growth Factor Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hepatocyte Growth Factor market is projected to grow from US$ 75.8 million in 2024 to US$ 426 million by 2031, at a CAGR of 28.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 143
USD 4900.00 (Single User License)Global Hepatocyte Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hepatocyte Growth Factor market size was US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 426 million by 2031 with a CAGR of 28.0% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 80
USD 4250.00 (Single User License)Global Hepatocyte Growth Factor Market Research Report 2025
The global market for Hepatocyte Growth Factor was valued at US$ 75.8 million in the year 2024 and is projected to reach a revised size of US$ 426 million by 2031, growing at a CAGR of 28.0% during the forecast period.
Published: 2025-08-13
Pages: 82
USD 2900.00 (Single User License)Global Hepatocyte Growth Factor Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million and is forecast to reach approximately US$ 464 million by 2031 with a CAGR of 30.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 140
USD 5900.00 (Single User License)Hepatocyte Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 464 million by 2031 with a CAGR of 30.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 98
USD 3950.00 (Single User License)Global Hepatocyte Growth Factor Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Published: 2024-04-17
Pages: 138
USD 5600.00 (Single User License)Global Hepatocyte Growth Factor Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Published: 2024-04-16
Pages: 128
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now